Marker Therapeutics, Inc.

Monthly Archives: June 2014

TapImmune Appoints Leading Immunotherapy Researcher to Chair Scientific Advisory Board

SEATTLE–(BUSINESS WIRE)– TapImmune Inc. (TPIV) is pleased to announce that Dr. Keith Knutson, PhD (www.vgtifl.org/keith-knutson-phd) has been appointed to chair the company’s scientific advisory board. Dr. Knutson is Director of the Cancer Vaccines and Immune Therapies Program at the Vaccine &
Read More